透過您的圖書館登入
IP:18.119.253.93
  • 學位論文

不同乳酸菌酛之發酵乳貯存期間對菌酛成長影響及消費者喜好度之研究

Effect of Different Strain Lactic Starters on Microbial Growth during Storage and Consumer Preference of Yogurt

指導教授 : 陳齊聖
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


發酵乳(yogurt)不僅是身體生長的優良蛋白質來源,更提供益生菌以促進腸道菌種平衡,增加人體健康與疾病防治。本研究選用Bifidobacterium bifidum(以下簡稱B菌)與Lactobacillus sporogenes(以下簡稱S菌)二株乳酸菌為低脂牛奶發酵乳之發酵菌酛。嘗試以單一菌酛生產發酵乳品,並瞭解此等產品置於低溫(4℃)貯存(14天)期間,微生物品質(存活乳酸菌數)及酸鹼值(pH)之變化。以市售菌粉(Culture Systems Inc., Mishawaka, IN 465495, USA)發酵之發酵乳作為對照組,比較三者間乳酸菌活性,及利用感官品評,瞭解一般消費者之喜好程度。 結果顯示,以S菌發酵之發酵乳於貯存14天後,比其他二種菌酛有較佳之微生物品質(1.43×109 CFU/mL)、最低pH(3.76)也獲得官能品評人員較高之喜好度分數(4.20分)。

並列摘要


Yogurt not only is a source of quality protein for human growth but also provides probiotics for ensuring bacteria balance in the intestines. In addition, it is beneficial to human health and is helpful in the prevention of many diseases. Two strains of lactic acid bacteria (Bifidobacterium bifidum, Lactobacillus sporogenes) were selected as the starter organisms in this research for the fermentation of the low fat yogurt. Single strain starter was adopted for making two kinds of yogurt. This research studied the variations of the microbial viability and pH during storage at 4℃for 14 days. The yogurt fermented using dried powder starter sold the market (Culture Systems Inc., Mishawaka, IN 465495, USA) as the control, for comparing microbial viability, pH after storage. Consumer preferences were also compared by sensory evaluation. Experimental results suggested that the yogurt made from Lactobacillus sporogeneshad provided higher microbial viability (1.43×109 CFU/mL), the lowest pH(3.76) and was given the highest hedonic level of (4.20) by test panel.

參考文獻


江孟燦,陳冠福,姚賢宗,劉凱崴,潘崇良,「以Lactobacillus plantarum BCRC12250 與Lactobacillus plantarum BCRC10069為發酵菌酛之優酪乳對大白鼠血脂質及肝臟脂質之影響」,台灣農業化學與食品科學,第43 卷第3 期,第175-181頁(2005)。
陳邦基,「益生菌與人體健康」,長庚醫訊,第33卷第8期,第37-43頁(2012)。
陳慶源、黃崇真、邱雪惠、廖啟成,「乳股菌之保健功效與產品開發」,農業生技產業季刊,第11期,第60-68頁(2007)。
莊子毅,「聚醣類賦形劑在乳酸菌粉生產之應用」,碩士論文,朝陽科技大學生化技術研究所,臺中(2009)。
Anja Hoffmann, Ulrike Pag, Imke Wiedemann, Hans-Georg Sahl, “Combination of antibiotic mechanisms in lantibiotics,” Il Farmaco, 57: 685-691 (2002).

延伸閱讀